Yingxue Jin | Pharmaco-Oncology | Excellence in Oncology Research Award

Prof. Dr. Yingxue Jin | Pharmaco-Oncology | Excellence in Oncology Research Award

Harbin Normal University | China

AUTHOR PROFILE

Scopus

🧑‍🏫 YINGXUE JIN – PROFESSIONAL PROFILE

🎓 EARLY ACADEMIC PURSUITS

Yingxue Jin embarked on his academic journey with a strong foundation in science, eventually earning a Doctor of Science degree from Pusan National University in Korea in 2003. His academic background laid the groundwork for his expertise in pharmaceutical engineering and drug design. During his doctoral studies, he specialized in small molecule cyclic peptide drugs and nanodrug delivery systems, establishing a solid base for his future research contributions.

💼 PROFESSIONAL ENDEAVORS

Yingxue Jin has accumulated over three decades of experience in academia and research, holding key positions in prestigious institutions and companies:

  • Professor at Jiamusi University (1990 – 1999): Contributed to teaching and research in pharmaceutical sciences.

  • Senior Researcher at Korea Ilshin Chemical Company (2003 – 2004): Engaged in advanced chemical research, expanding his expertise in molecular synthesis.

  • Postdoctoral Researcher at Taiwan University, China (2005 – 2006): Conducted postdoctoral studies, refining his knowledge in pharmaceutical engineering and drug delivery mechanisms.

  • Professor at Harbin Normal University, China (2006 – Present):

    • Serving as Head of the Department of Pharmaceutical Engineering.

    • Director of Heilongjiang Chemical Society of China, promoting chemical science advancements.

    • Awarded the honorary title of “Famous Teacher” at Harbin Normal University, recognizing his excellence in education and mentorship.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACO-ONCOLOGY

Yingxue Jin’s primary research interests revolve around:

  • Design and Synthesis of Small Molecule Cyclic Peptide Drugs: Developing novel peptide-based therapeutic agents for various diseases, including cancer.

  • Anti-Tumor Nanodrug Delivery Systems: Innovating targeted drug delivery methods to enhance the efficacy and precision of cancer treatments.

  • Project Leadership:

    • Presided over two projects funded by the Natural Science Foundation of China (NSFC).

    • Led the implementation of one key project and two general projects under the Natural Science Foundation of Heilongjiang Province, China.

    • Supervised three natural science projects for the Heilongjiang Provincial Education Department, China.

🏅 IMPACT AND INFLUENCE

Yingxue Jin’s impactful contributions have been widely recognized through multiple awards and honors:

  • Natural Science and Technology Award of Heilongjiang Province: Acknowledging his significant scientific achievements.

  • Science and Technology Award of Heilongjiang Provincial Education Department: Recognizing his contributions to technological advancements in education.

  • Teaching Quality Award at Harbin Normal University (Multiple Occasions): Honoring his dedication to educational excellence and mentorship.

📚 ACADEMIC CITATIONS

Throughout his career, Yingxue Jin’s research has been widely cited in scientific publications, reflecting the influence and relevance of his work in the fields of pharmaceutical sciences, chemical engineering, and nanomedicine. His contributions have been referenced in numerous peer-reviewed journals, further establishing his reputation as a leading researcher in his field.

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Yingxue Jin’s legacy is marked by his dedication to scientific innovation, educational mentorship, and pharmaceutical advancements. Moving forward, he aims to:

  • Expand his research in nanodrug delivery systems, focusing on precision medicine for oncology applications.

  • Foster collaborations with international research institutions to drive cross-disciplinary advancements.

  • Continue mentoring the next generation of scientists, contributing to the development of future leaders in pharmaceutical sciences.

🛡️ KEY ACHIEVEMENTS AND RECOGNITION

  • Honorary Title: Famous Teacher of Harbin Normal University.

  • Leadership Roles: Head of the Department of Pharmaceutical Engineering and Director of Heilongjiang Chemical Society of China.

  • Award-Winning Scientist: Recipient of multiple science and technology awards.

  • Renowned Educator: Consistently recognized for outstanding teaching quality.

🚀 CONCLUSION

Yingxue Jin’s extensive experience, innovative research, and dedication to scientific excellence and education have positioned him as a distinguished figure in the field of pharmaceutical sciences. His continued contributions to nanodrug delivery systems and cyclic peptide drug design are paving the way for groundbreaking advancements in cancer treatment and precision medicine.

 

📊🔬NOTABLE PUBLICATION:
  • 1️⃣ Exploring the Potential of Cyclic Peptidyl Antitumor Agents Derived from Natural Macrocyclic Peptide Phakellistatin 13

    Authors: Tong T. Li, Shitian S. Jiang, Tingting T. Li, Yingxue Y. Jin, Zhiqiang Z. Wang
    Journal: Journal of Medicinal Chemistry
    Year: 2024


    2️⃣ Enhanced Catalytic Activity of Fe3O4-Carbon Dots Complex in the Fenton Reaction for Enhanced Immunotherapeutic and Oxygenation Effects

    Authors: Guanghao G. Li, Yujun Y. Bao, Hui H. Zhang, Zhiqiang Z. Wang, Yingxue Y. Jin
    Journal: Journal of Colloid and Interface Science
    Year: 2024


    3️⃣ A Novel Nanomedicine Integrating Ferroptosis and Photothermal Therapy, Well-Suitable for PD-L1-Mediated Immune Checkpoint Blockade

    Authors: Yujun Y. Bao, Guanghao G. Li, Siqi S. Li, Changhong C. Guo, Yingxue Y. Jin
    Journal: Materials Today Bio
    Year: 2024


    4️⃣ Targeted Delivery of Rhein via Hyaluronic Acid Modified Liposomes for Suppression of Growth and Metastasis of Breast Cancer

    Authors: Jingchun J. Wang, Dijing D. Fan, Defu D. Cai, Yingxue Y. Jin
    Journal: International Journal of Biological Macromolecules
    Year: 2024


    5️⃣ DFT-Aided Stereo-Structural and Electronic Structure Studies of Poly-Hydroxyl Substituted Chlorophyllous Molecules

    Authors: Xiong X. Zhang, Tingting T. Li, Qi Q. Wang, Wen W. Fang, Zhiqiang Z. Wang
    Journal: Computational and Theoretical Chemistry
    Year: 2024

Guohua Yang | Medical Genetics | Best Researcher Award

Assoc. Prof. Dr. Guohua Yang | Medical Genetics | Best Researcher Award

Wuhan University | China

Author Profile

ORCID ID

🔬🧬 Prof. Guohua Yang – Associate Professor, Wuhan University

Expert in Medical Genetics & Precision Medicine

🏛️ Institution: Wuhan University
🎓 Academic Focus: Medical Genetics, Gene Mutation & Disease Mechanisms

🔍 Research Interests:

  • 🧬 Gene Mutations & Genetic Diseases – Understanding the functional impact of genetic variations.
  • 🏥 Innovative Gene Diagnosis – Developing cutting-edge diagnostic methods for hereditary conditions.
  • 🦠 Hepatocellular Carcinoma – Investigating molecular mechanisms and drug discovery strategies.

📌 Leadership & Professional Roles:

  • 👨‍⚕️ Chairman, Gene Health Branch, Hubei Genetic Society
  • 🏥 Standing Committee Member, Reproductive Genetics Branch, Hubei Reproductive Health Society
  • 🧑‍⚕️ Member, Medical Genetics Branch, Hubei Medical Association
  • 👶 Committee Member, Fertility Protection & Restoration, China Association for Healthy Children
  • 🏥 Deputy Director, Precision Medicine Committee, Zhongguancun Cancer Minimally Invasive Treatment Alliance

📚 Editorial Appointments:

  • ✍️ Guest Editor, Frontiers in Genetics (Monogenic Diseases Column)
  • 📖 Editorial Board Member, Spandidos Journal, Brain Research

🏆CONCLUSION 

Prof. Guohua Yang is a leading expert in medical genetics and precision medicine, making significant contributions to gene mutation research, innovative genetic diagnostics, and hepatocellular carcinoma treatment. As a key figure in multiple academic and professional organizations, his leadership and editorial roles further strengthen his impact in the field. His dedication to advancing genetic research and clinical applications continues to shape the future of genomic medicine and personalized healthcare. 🏥🧬

 

📊🔬NOTABLE PUBLICATION:
  • Title: Clinic Examination and Gene Diagnosis for a Birt–Hogg–Dubé Syndrome Family With a Novel FLCN Frameshift Mutation Causing Nonsense‐Mediated mRNA Degradation.
    Authors: 
    Yang Xu, Jie Gao, Yang An, Chenxi Zou, Guoqing Ding, Guohua Yang, Finlay Macrae.
    Journal: Human Mutation
    Year: 2025

 

  • Title: A Novel TSC1 Frameshift Mutation c.1550_1551del Causes Tuberous Sclerosis Complex by Aberrant Splicing and Nonsense‐Mediated mRNA Degradation (NMD) Simultaneously in a Chinese Family.
    Authors:
     Cong Qiu, Chengyan Li, Xiaoyun Tong, Luoyang Dai, Wenda Liu, Yulie Xie, Qimei Zhang, Guohua Yang, Tao Li.
    Journal: Molecular Genetics & Genomic Medicine
    Year: 2020

 

  • Title: Identification and Interaction Analysis of Significant Genes and MicroRNAs in Pterygium.
    Authors:
     Siying He, Hui Sun, Yifang Huang, Shiqi Dong, Chen Qiao, Shuai Zhang, Chen Wang, Fang Zheng, Ming Yan, Guohua Yang.
    Journal: BioMed Research International
    Year: 2019